These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36481320)

  • 1. Mesenchymal stem/stromal cells from a transplanted, asymptomatic patient with Fanconi anemia exhibit an aging-like phenotype and dysregulated expression of genes implicated in hematopoiesis and myelodysplasia.
    Haga CL; Boregowda SV; Booker CN; Krishnappa V; Strivelli J; Cappelli E; Phinney DG
    Cytotherapy; 2023 Apr; 25(4):362-368. PubMed ID: 36481320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production.
    Cagnan I; Gunel-Ozcan A; Aerts-Kaya F; Ameziane N; Kuskonmaz B; Dorsman J; Gumruk F; Uckan D
    Stem Cell Rev Rep; 2018 Jun; 14(3):425-437. PubMed ID: 29247345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced Cell Division Control Protein 42 Activity Compromises Hematopoiesis-Supportive Function of Fanconi Anemia Mesenchymal Stromal Cells.
    Xu J; Li X; Cole A; Sherman Z; Du W
    Stem Cells; 2018 May; 36(5):785-795. PubMed ID: 29377497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the mesenchymal stromal cells in bone marrow failure of Fanconi Anemia patients.
    Zubicaray J; Ivanova M; Iriondo J; García Martínez J; Muñoz-Viana R; Abad L; García-García L; González de Pablo J; Gálvez E; Sebastián E; Ramírez M; Madero L; Díaz MÁ; González-Murillo Á; Sevilla J
    Front Cell Dev Biol; 2024; 12():1286815. PubMed ID: 39119037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired functionality and homing of Fancg-deficient hematopoietic stem cells.
    Barroca V; Mouthon MA; Lewandowski D; Brunet de la Grange P; Gauthier LR; Pflumio F; Boussin FD; Arwert F; Riou L; Allemand I; Romeo PH; Fouchet P
    Hum Mol Genet; 2012 Jan; 21(1):121-35. PubMed ID: 21968513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.
    Geyh S; Rodríguez-Paredes M; Jäger P; Koch A; Bormann F; Gutekunst J; Zilkens C; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
    Haematologica; 2018 Sep; 103(9):1462-1471. PubMed ID: 29773599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonality studies and N-ras and p53 mutation analysis of hematopoietic cells in Fanconi anemia.
    Venkatraj VS; Gaidano G; Auerbach AD
    Leukemia; 1994 Aug; 8(8):1354-8. PubMed ID: 8057673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive characterization of mesenchymal stromal cells from patients with Fanconi anaemia.
    Mantelli M; Avanzini MA; Rosti V; Ingo DM; Conforti A; Novara F; Arrigo G; Boni M; Zappatore R; Lenta E; Moretta A; Acquafredda G; de Silvestri A; Cirillo V; Cicchetti E; Algeri M; Strocchio L; Vinti L; Starc N; Biagini S; Sirleto P; Bernasconi P; Zuffardi O; Maserati E; Maccario R; Zecca M; Locatelli F; Bernardo ME
    Br J Haematol; 2015 Sep; 170(6):826-36. PubMed ID: 26010568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global miRNA expression of bone marrow mesenchymal stem/stromal cells derived from Fanconi anemia patients.
    Cagnan I; Keles M; Keskus AG; Tombaz M; Sahan OB; Aerts-Kaya F; Uckan-Cetinkaya D; Konu O; Gunel-Ozcan A
    Hum Cell; 2022 Jan; 35(1):111-124. PubMed ID: 34792755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematological consequences of a FANCG founder mutation in Black South African patients with Fanconi anemia.
    Feben C; Kromberg J; Wainwright R; Stones D; Poole J; Haw T; Krause A
    Blood Cells Mol Dis; 2015 Mar; 54(3):270-4. PubMed ID: 25477267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fanconi Anemia Mesenchymal Stromal Cells-Derived Glycerophospholipids Skew Hematopoietic Stem Cell Differentiation Through Toll-Like Receptor Signaling.
    Amarachintha S; Sertorio M; Wilson A; Li X; Pang Q
    Stem Cells; 2015 Nov; 33(11):3382-96. PubMed ID: 26212365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric analysis of etoposide exposed mesenchymal stem cells and Fanconi anemia cells: implications in development of secondary myeloid malignancy.
    Özdemir C; Muratoğlu B; Özel BN; Alpdündar-Bulut E; Tonyalı G; Ünal Ş; Uçkan-Çetinkaya D
    Clin Exp Med; 2023 Dec; 23(8):4511-4524. PubMed ID: 37179284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fanconi anemia and the development of leukemia.
    Alter BP
    Best Pract Res Clin Haematol; 2014; 27(3-4):214-21. PubMed ID: 25455269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
    Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
    Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Hematopoietic Gene Therapy in a Mouse Model of Fanconi Anemia Mediated by Mesenchymal Stromal Cells.
    Fernández-García M; Luisa Lamana M; Hernando-Rodríguez M; Sánchez-Domínguez R; Bueren J; Yañez R
    Hum Gene Ther; 2018 Mar; 29(3):327-336. PubMed ID: 28816065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow microenvironment in fanconi anemia: a prospective functional study in a cohort of fanconi anemia patients.
    Lecourt S; Vanneaux V; Leblanc T; Leroux G; Ternaux B; Benbunan M; Chomienne C; Baruchel A; Marolleau JP; Gluckman E; Socié G; Soulier J; Larghero J
    Stem Cells Dev; 2010 Feb; 19(2):203-8. PubMed ID: 19572808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic disruption of both Fancc and Fancg in mice recapitulates the hematopoietic manifestations of Fanconi anemia.
    Pulliam-Leath AC; Ciccone SL; Nalepa G; Li X; Si Y; Miravalle L; Smith D; Yuan J; Li J; Anur P; Orazi A; Vance GH; Yang FC; Hanenberg H; Bagby GC; Clapp DW
    Blood; 2010 Oct; 116(16):2915-20. PubMed ID: 20606166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.
    Faivre L; Guardiola P; Lewis C; Dokal I; Ebell W; Zatterale A; Altay C; Poole J; Stones D; Kwee ML; van Weel-Sipman M; Havenga C; Morgan N; de Winter J; Digweed M; Savoia A; Pronk J; de Ravel T; Jansen S; Joenje H; Gluckman E; Mathew CG
    Blood; 2000 Dec; 96(13):4064-70. PubMed ID: 11110674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiologic differences between bone marrow stromal and hematopoietic progenitor cell lines from Fanconi Anemia (Fancd2(-/-)) mice.
    Berhane H; Epperly MW; Goff J; Kalash R; Cao S; Franicola D; Zhang X; Shields D; Houghton F; Wang H; Wipf P; Parmar K; Greenberger JS
    Radiat Res; 2014 Jan; 181(1):76-89. PubMed ID: 24397476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An abnormal bone marrow microenvironment contributes to hematopoietic dysfunction in Fanconi anemia.
    Zhou Y; He Y; Xing W; Zhang P; Shi H; Chen S; Shi J; Bai J; Rhodes SD; Zhang F; Yuan J; Yang X; Zhu X; Li Y; Hanenberg H; Xu M; Robertson KA; Yuan W; Nalepa G; Cheng T; Clapp DW; Yang FC
    Haematologica; 2017 Jun; 102(6):1017-1027. PubMed ID: 28341737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.